Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

110.68
-0.4600-0.41%
Volume:32.56K
Turnover:3.60M
Market Cap:1.01B
PE:89.68
High:111.04
Open:111.04
Low:110.01
Close:111.14
52wk High:118.00
52wk Low:85.91
Shares:9.09M
Float Shares:9.09M
Volume Ratio:0.47
T/O Rate:0.36%
Dividend:2.18
Dividend Rate:1.97%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):142.54

Loading ...

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
37 mins ago

Novo CEO Urges Staff to Embrace More Customer-Focused Culture

Reuters
·
52 mins ago

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
1 hour ago

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
1 hour ago

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
1 hour ago

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
1 hour ago

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
1 hour ago

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
1 hour ago

Sector Update: Healthcare

MT Newswires Live
·
2 hours ago

Legend Biotech Taps Novartis Veteran Zhang as CEO

Reuters
·
2 hours ago

Novo Nordisk Stock (NVO) Is Falling Despite Rebrand to ‘Novo’ — Here’s Why

TIPRANKS
·
3 hours ago

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
3 hours ago

Testosterone Scripts for Women Rise, Along with Denials and Delays

Reuters
·
5 hours ago

Novo Nordisk rebranding as ‘Novo,’ announces cultural reset

TIPRANKS
·
5 hours ago

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
6 hours ago

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
6 hours ago

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
10 hours ago

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

TIPRANKS
·
13 hours ago

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
13 hours ago

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
18 hours ago